MIV THERAPEUTICS FILES BOTH US AND INTERNATIONAL PATENTS FOR BREAKTHROUGH SMART III NANOPARTICLE DRUG DELIVERY SYSTEM

MIV Therapeutics, a developer of next-generation biocompatible stent coatings and drug delivery technologies, recently announced the filing of landmark U.S. and international Patent Cooperation Treaty patent applications for the newest member of its advanced "Smart" drug delivery systems, designed to meet the individual needs of millions of patients.
Business Wire